Brain zap trial offers hope for drug-resistant epilepsy patients
NCT ID NCT06436547
First seen Nov 19, 2025 · Last updated Apr 29, 2026 · Updated 27 times
Summary
This small pilot study tests whether deep brain stimulation (DBS) of a brain region called the subiculum can safely reduce seizure frequency in people with drug-resistant temporal lobe epilepsy and bilateral hippocampal sclerosis. Six participants receive the implant and are monitored for changes in seizure counts and quality of life. The goal is to control seizures, not cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY, DRUG RESISTANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, 100053, China
Conditions
Explore the condition pages connected to this study.